Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (111-120 of 494) with videos related to

Pageof 50
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Prevalence of KIT expression in human tumorsPhilip Th Went, Stephan Dirnhofer, Marcel Bundi, et al.
Human Pathology|November 10, 2009
Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancerMatthias Choschzick, Annette Lebeau, Andreas H Marx, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 27, 2012
Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancerAnna Flammiger, Florian Bayer, Ana Cirugeda-Kühnert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 9, 2010
Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcomeMatthias Choschzick, Paula Lassen, Annette Lebeau, et al.
International Journal of Oncology|July 13, 2005
High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancerPeter J Wild, Leoni A Kunz-Schughart, Robert Stoehr, et al.
International Journal of Oncology|November 18, 2004
HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsiesCoya Tapia, Peter Schraml, Ronald Simon, et al.
Oncology Reports|November 9, 2017
IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissuesChristoph Burdelski, Nilofar Jakani-Karimi, Frank Jacobsen, et al.
Human Pathology|May 7, 2013
Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrenceMaria Christina Tsourlakis, Michael Schoop, Christoph Plass, et al.
Human Pathology|May 31, 2006
High frequency and strong prognostic relevance of O6-methylguanine DNA methyltransferase silencing in diffuse large B-cell lymphomas from the Middle EastKhawla Al-Kuraya, Rajeswari Narayanappa, Abdul Khalid Siraj, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|June 23, 2017
High-level βIII-tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcomeJulie C Nienstedt, Alexander Gröbe, Till Clauditz, et al.
Pageof 50

Showing results (111-120 of 494) with videos related to

Sort By:
Pageof 50
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Prevalence of KIT expression in human tumorsPhilip Th Went, Stephan Dirnhofer, Marcel Bundi, et al.
Human Pathology|November 10, 2009
Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancerMatthias Choschzick, Annette Lebeau, Andreas H Marx, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 27, 2012
Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancerAnna Flammiger, Florian Bayer, Ana Cirugeda-Kühnert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 9, 2010
Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcomeMatthias Choschzick, Paula Lassen, Annette Lebeau, et al.
International Journal of Oncology|July 13, 2005
High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancerPeter J Wild, Leoni A Kunz-Schughart, Robert Stoehr, et al.
International Journal of Oncology|November 18, 2004
HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsiesCoya Tapia, Peter Schraml, Ronald Simon, et al.
Oncology Reports|November 9, 2017
IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissuesChristoph Burdelski, Nilofar Jakani-Karimi, Frank Jacobsen, et al.
Human Pathology|May 7, 2013
Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrenceMaria Christina Tsourlakis, Michael Schoop, Christoph Plass, et al.
Human Pathology|May 31, 2006
High frequency and strong prognostic relevance of O6-methylguanine DNA methyltransferase silencing in diffuse large B-cell lymphomas from the Middle EastKhawla Al-Kuraya, Rajeswari Narayanappa, Abdul Khalid Siraj, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|June 23, 2017
High-level βIII-tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcomeJulie C Nienstedt, Alexander Gröbe, Till Clauditz, et al.
Pageof 50